Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
Authors
Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
Kim Papp, Matthias Augustin, Eric L. Simpson, Haobo Ren et al.
Citations
12 citations
Journal
American Journal of Clinical Dermatology
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
6.42
article
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
Kim Papp, Matthias Augustin, Eric L. Simpson, Haobo Ren, Daniel Sturm, Mark Boguniewicz, Leon Kircik, Shawn G. Kwatra, Jacek Cezary Szepietowski, Howard Kallender, Andrew Blauvelt, Diamant Thaçi, L. Misery, April W Armstrong
article en
12 citations
Abstract
No abstract available for this paper.
Publication Tag
American Journal of Clinical DermatologyVol. 26(1)
Institutions
Wrocław University of Science and Technology (PL), University of Maryland, Baltimore (US), Universität Hamburg (DE), University of California, Los Angeles (US), Oregon Health & Science University (US), University of Toronto (CA), National Jewish Health (US), University Medical Center Hamburg-Eppendorf (DE), Probity Medical Research (CA), Oregon Medical Research Center (US), Centre Hospitalier Régional Universitaire de Brest (FR), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), AGH University of Krakow (PL), University of Colorado Denver (US), Incyte (United States) (US), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US)